SeLux Diagnostics, Inc.
Charlestown, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into SeLux Diagnostics, Inc.
126 people in our graph share verified history with the SeLux Diagnostics, Inc. team — schools, employers, funds. One of them is your warm intro.
Stacey Herounlockedknows Aleksandar Vacic · together at Yale University (overlapped)
×5knows the team · via Yale University
knows the team · via SeLux Diagnostics, Inc.
×4knows the team · via Weizmann Institute of Science
knows the team · via University of Belgrade
Founders & leadership
SeLux Diagnostics, Inc. was founded in 2014 by Eric Stern and Aleksandar Vacic.
ES
Eric SternCo-founder
AV
Aleksandar VacicinCo-founder · President, Product, Engineering and Manufacturing2015–2025Aleksandar Vacic has led product development and technology strategies in semiconductors, life science, and defense/security sectors, with experience building cross-functional teams to bring regulated products from development through production.
JP
James Parker CassidyNamed on SEC filing
SY
Scott YapheNamed on SEC filing
SE
Steven E. LufkinNamed on SEC filing
MR
Michael RubinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$124M disclosed across 6 rounds · 2018–2024
▶$40MraisedFeb 2024 · 9 investors · BiotechnologyRule 506(b)
▶$40MraisedFeb 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michele HealyExecutive Officer
- Jamie CondieDirector
- Orhan GazelleDirector
- John WilsonExecutive Officer
- Eric SternExecutive Officer, Director
- Ingo ChakravartyDirector
- Steven E. LufkinExecutive Officer, Director
- James Parker CassidyDirector
- Erich SchellerDirector
- Adam SteelExecutive Officer
- Aleksandar VacicExecutive Officer
- Offering amount
- $45M
- Amount sold
- $40M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$48.2MraisedFeb 2022 · 25 investors · BiotechnologyRule 506(b)
▶$48.2MraisedFeb 2022 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott YapheDirector
- Aleksandar VacicExecutive Officer
- James Parker CassidyDirector
- Eric SternExecutive Officer, Director
- Erich SchellerDirector
- Jack PercoskieExecutive Officer
- Steven E. LufkinExecutive Officer, Director
- Offering amount
- $57.6M
- Amount sold
- $48.2M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJun 2021 · 25 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJun 2021 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. LufkinExecutive Officer, Director
- Parker CassidyDirector
- Vacic AlexanderExecutive Officer
- Stephen ZacharyDirector
- Eric SternExecutive Officer, Director
- Jack PercoskieExecutive Officer
- Scott YapheDirector
- Offering amount
- $7.5M
- Amount sold
- $2.5M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$813.9KraisedOct 2020 · 1 investors · BiotechnologyRule 506(b)
▶$813.9KraisedOct 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. LufkinExecutive Officer, Director
- Aleksandar VacicExecutive Officer, Promoter
- Eric SternExecutive Officer, Director, Promoter
- James Parker CassidyDirector
- Stephen ZacharyDirector
- Jack PercoskieExecutive Officer
- Scott YapheDirector
- Offering amount
- $1.7M
- Amount sold
- $813.9K
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedSep 2019 · 27 investors · BiotechnologyRule 506(b)
▶$9MraisedSep 2019 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven E. LufkinExecutive Officer, Director
- Aleksandar VacicExecutive Officer, Promoter
- Eric SternExecutive Officer, Director, Promoter
- James Parker CassidyDirector
- Scott YapheDirector
- Stephen ZacharyDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$23.5MraisedApr 2018 · 5 investors · BiotechnologyRule 506(b)
▶$23.5MraisedApr 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SternExecutive Officer, Director, Promoter
- James Parker CassidyDirector
- Scott YapheDirector
- Steven E. LufkinExecutive Officer, Director
- Aleksandar VacicExecutive Officer, Promoter
- Michael RubinDirector
- Offering amount
- $25M
- Amount sold
- $23.5M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with SeLux Diagnostics, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $298.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $216.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded SeLux Diagnostics, Inc.?
- SeLux Diagnostics, Inc. was founded by Eric Stern, Aleksandar Vacic in 2014.
- Who are SeLux Diagnostics, Inc.'s investors?
- SeLux Diagnostics, Inc.'s investors include Sands Capital Ventures.
- How much funding has SeLux Diagnostics, Inc. raised?
- SeLux Diagnostics, Inc. has disclosed $124M raised across 6 rounds.
- Where is SeLux Diagnostics, Inc. headquartered?
- SeLux Diagnostics, Inc. is headquartered in Charlestown, US.